Trending stocks today
Cassava Sciences (SAVA-Q)
NASDAQ:SAVA
28.43
0.45
(1.56%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Based on the reviews from different experts, it is evident that Cassava Sciences (SAVA-Q) is not performing well financially, as it is losing a lot of money. The experts are unable to recommend investing in this company or its stock. This indicates that the company may be facing challenges in terms of profitability and financial stability. Investors should consider these factors before making any decisions regarding this stock.
$18.550
Unknown
It loses a lot of money. Can't recommend any of those companies.
- «
- ‹
- 1
- ›
- »
Cassava Sciences(SAVA-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Cassava Sciences(SAVA-Q) Frequently Asked Questions
What is Cassava Sciences stock symbol?
Cassava Sciences is a American stock, trading under the symbol SAVA-Q on the NASDAQ (SAVA). It is usually referred to as NASDAQ:SAVA or SAVA-Q
Is Cassava Sciences a buy or a sell?
In the last year, 1 stock analyst published opinions about SAVA-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cassava Sciences.
Is Cassava Sciences a good investment or a top pick?
Cassava Sciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cassava Sciences.
Why is Cassava Sciences stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Cassava Sciences worth watching?
In the last year, there was no coverage of Cassava Sciences published on Stockchase.
What is Cassava Sciences stock price?
On 2024-10-22, Cassava Sciences (SAVA-Q) stock closed at a price of $28.43.
If they produce a big drug, shares can triple, but if they don't, then shares drift down. He likes the risk/reward ratio.